SEC Form 4 · accession 0001127602-18-032653
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P. Mr. Burke
Officer — EVP, Chief Financial Officer
Period of report
Nov 8, 2018
Accepted (ET)
Nov 9, 2018 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 8, 2018 | M | 11,232 | $34.21 | A | 25,057 | D | |
| Common StockF2 | Nov 8, 2018 | S | 13,056 | $114.33 | D | 12,001 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F3 | $34.21 | Nov 8, 2018 | M | 11,232 | D | Oct 25, 2017 | Oct 25, 2023 | Common Stock | 11,232 | 22,463 | D |
Explanation of responses
- F1Transaction pursuant to an existing 10b5-1 trading plan.
- F2This number includes unvested restricted stock units previously reported.
- F3Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.